Yoshiki Hirooka
Toyoake, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 387 publications
Agaro-Oligosaccharides Modulate Gut Microbiota to Improve Lipid Metabolism in Obesity Model Rats.
Journal: Journal of nutritional science and vitaminology
Published: August 30, 2026
A qPCR-based approach targeting the microbial gene marker nanA of mucin-degrading Akkermansia in Parkinson's disease.
Journal: Journal of Parkinson's disease
Published: August 11, 2026
1-Kestose as a Candidate Precision Bioactive Component: From GH32-Dependent Gut Microbiota Regulation to Human Health Enhancement.
Journal: Foods (Basel, Switzerland)
Published: June 16, 2026
Clinical Utility and Genomic Landscape of Comprehensive Genomic Profiling in Biliary Tract Tumors: A Single-Center Real-World Study.
Journal: Cancers
Published: June 14, 2026
Disease-specific gut microbial signatures generate model-derived cancer probability scores through targeted fecal qPCR profiling.
Journal: Bioscience, biotechnology, and biochemistry
Published: April 22, 2026
Superior accuracy of a novel multidimensional index integrating static and dynamic liver stiffness for hepatocellular carcinoma risk prediction in chronic hepatitis B.
Journal: Journal of medical ultrasonics (2001)
Published: March 31, 2026
Agaro-Oligosaccharide Supplementation Alters the Gut Microbiota, Revealing Potential Agaro-Oligosaccharide-Utilizing Taxa in Healthy Japanese Adults.
Journal: Biomedicines
Published: March 17, 2026
Diagnostic Pathways and Outcomes of First-Line Atezolizumab plus Bevacizumab in Patients with Locoregional Therapy-Ineligible Hepatocellular Carcinoma at Initial Diagnosis.
Journal: Oncology
Published: January 21, 2026
Foveolar-Type Gastric Adenoma With a Raspberry-Like Appearance That Underwent Dramatic Morphological Changes Within Eight Months.
Journal: Case reports in gastrointestinal medicine
Published: January 05, 2026
Last Updated: 09/26/2026